Loading...
Loading...
Click here if you don’t see subscription options
Handout image shows a mouse embryo formed with Stimulus-Triggered Acquisition of Pluripotency (STAP) cells. (CNS photo/Haruko Obokata, RIKEN Center for Developmental Biology handout via Reuters)

A new method of creating versatile stem cells from a relatively simple manipulation of existing cells could further reduce the need for research involving human embryos. Although the process has been tested only in mice, two studies published on Jan. 29 in the journal Nature detailed research showing success with a process called stimulus-triggered acquisition of pluripotency, or S.T.A.P. Scientists from Japan’s Riken research institute and Harvard’s Brigham and Women’s Hospital in Boston were able to reprogram blood cells from newborn mice by placing them in a low-level acidic bath for 30 minutes. “If this technology proves feasible with human cells, which seems likely, it will offer yet another alternative for obtaining highly flexible stem cells without relying on the destructive use of human embryos,” said the Rev. Tadeusz Pacholczyk, director of education at the National Catholic Bioethics Center in Philadelphia.

Comments are automatically closed two weeks after an article's initial publication. See our comments policy for more.

The latest from america

I use a motorized wheelchair and communication device because of my disability, cerebral palsy. Parishes were not prepared to accommodate my needs nor were they always willing to recognize my abilities.
Margaret Anne Mary MooreNovember 22, 2024
Nicole Scherzinger as ‘Norma Desmond’ and Hannah Yun Chamberlain as ‘Young Norma’ in “Sunset Blvd” on Broadway at the St. James Theatre (photo: Marc Brenner).
Age and its relationship to stardom is the animating subject of “Sunset Blvd,” “Tammy Faye” and “Death Becomes Her.”
Rob Weinert-KendtNovember 22, 2024
What separates “Bonhoeffer” from the myriad instructive Holocaust biographies and melodramas is its timing.
John AndersonNovember 22, 2024
“Wicked” arrives on a whirlwind of eager (and anxious) anticipation among fans of the musical.
John DoughertyNovember 22, 2024